Sourcing a chemical succession for cyclosporin from parasites and human pathogens

Drug Discovery Today

Volumn 10, Issue 10, 2005, Pages 688-691

  Pritchard, David I ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 HEPTYL 3 HYDROXY 4 QUINOLONE; CYCLOSPORIN A; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; N (3 OXODODECANOYL)HOMOSERINE LACTONE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ALLERGY; ASTHMA; AUTOIMMUNE DISEASE; BACILLUS ANTHRACIS; BRUCELLA; BURKHOLDERIA; CANDIDA ALBICANS; DRUG INDUSTRY; ENTERITIS; GRAFT SURVIVAL; HELIGMOSOMOIDES POLYGYRUS; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; METABOLOMICS; MYCOBACTERIUM; NECATOR AMERICANUS; PSEUDOMONAS AERUGINOSA; REVIEW; TRICHURIS; YERSINIA;

EID: 19444363444     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03395-7     Document Type: Short Survey

References (32)

1. Borel J.F. Biological effects of cyclosporin A: A new antilymphocyte agent Agents Action 6 1976 468 475
2. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506 Immunol. Today 13 1992 136 142
3. Sehgal S.N. Sirolimus: Its discovery, biological properties, and mechanism of action Transplant. Proc. 35 2003 7S 14S
4. Harding M.W. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase Nature 341 1989 758 760
5. Fretz H. Rapamycin and FK506 binding proteins (Immunophilins): Communications to the Editor J. Am. Chem. Soc. 113 1991 1409 1411
6. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward Immunopharmacology 47 2000 63 83
7. Peric-Concha N., Long P.F. Mining the microbial metabolome: a new frontier for natural product lead discovery Drug Discov. Today 8 2003 1078 1084
8. Haefner B. Drugs from the deep: marine natural products as drug candidates Drug Discov. Today 8 2003 536 544
9. Simmonds M.S.J. Novel drugs from botanical sources Drug Discov. Today 8 2003 721 722
10. Harvey A. Strategies for discovering drugs from previously unexplored natural products Drug Discov. Today 5 2000 294 300
11. Akbari O. Role of regulatory T cells in allergy and asthma Curr. Opin. Immunol. 15 2003 627 633
12. Telford G. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-Oxododecanoyl)-L-homoserine lactone has immunomodulatory activity Infect. Immun. 66 1998 36 42
13. Hooi D.S.W. Differential immune modulatory activity of Pseudomonas aeruginosa quorum sensing signal molecules (QSSM) Infect. Immun. 72 2004 6463 6470
14. Zhou L. Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells Respir. Physiol. Neurobiol. 140 2004 89 97
15. Pujol, C. and Bliska, J.B. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin. Immunol. (in press)
16. Guidi-Rontani C. The alveolar macrophage: the Trojan horse of Bacillus anthracis Trends Microbiol. 10 2002 405 409
17. Letesson J-J. Fun stories about Brucella: the "furtive nasty bug" Vet. Microbiol. 90 2002 317 328
18. White N.J. Melioidosis Lancet 361 2003 1715 1722
19. Venturi V. Quorum sensing in the Burkholderia cepacia complex Res. Microbiol. 155 2004 238 244
20. Hasan Z. The effect of mycobacterial virulence and viability on MAP kinase signalling and TNFa production by human monocytes Tuberculosis (Edinb.) 83 2003 299 309
21. Mansour M.K., Levitz S.M. Interactions of fungi with phagocytes Curr. Opin. Microbiol. 5 2002 359 365
22. Telford G. Heligmosomoides polygyrus immunomodulatory factor (IMF), targets T-lymphocytes Parasite Immunol. 20 1998 601 611
23. Pritchard D.I., Brown A. Is Necator americanus approaching a mutualistic symbiotic relationship with humans? Trends Parasitol. 17 2001 159 207
24. Scrivener S. Independent effects of intestinal parasite infection and domestic allergen exposure on the risk of wheeze in Ethiopia Lancet 358 2001 1493 1499
25. Elliott D.E. Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J. 14 2000 1848 1855
26. Lavelle E. Molecules of infectious agents as immunomodulatory drugs Curr. Top. Med. Chem. 4 2004 499 508
27. Li L. Bacterial N-acylhomoserine lactone-induced apoptosis in breast carcinoma cells correlated with down-modulation of STAT3 Oncogene 23 2004 4894 4902
28. Luo C., Laaja P. Inhibitors of JAKSSTATs and the kinases: a possible new cluster of drugs Drug Discov. Today 9 2004 268 275
29. Wong W.S.F., Leong K.P. Tyrosine kinase inhibitors: a new approach for asthma Biochim. Biophys. Acta 1697 2004 53 69
30. Falcone, F.H. and Pritchard, D.I. Parasite role reversal: worms on trial. Trends Parasitol. (in press)
31. Sadeghi R. Differential regulation of CD3- and CD28-induced IL-2 and IFN-g production by a novel tyrosine kinase inhibitor XR774 from Cladosporium cf. cladosporioides Int. Immunopharmacol. 1 2001 33 48
32. Abel U. Modern methods to produce natural-product libraries Curr. Opin. Chem. Biol. 6 2002 453 458